Advertisement
Screener

SIGHT SCIENCES, INC. (SGHT) EBITDA

SIGHT SCIENCES, INC. (SGHT) EBITDA

  • 2026-06-30: Basis Reported; EBITDA -$3.79M*; Operating income -$3.89M; Depreciation and amortization $94.00K*.
  • 2026-03-31: Basis Reported; EBITDA -$12.31M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA -$3.56M; Operating income (m); Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA -$7.80M*; Operating income -$7.91M; Depreciation and amortization $105.00K*.

Complete source-backed ebitda history.

Available history
2023-03-31 to 2026-03-31
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported-$3.79M*-$3.89M$94.00K*$23.39M-16.22%*$19.00K*-$5.66M*$2.01M$2.51M$22.75M$28.00K
2026-03-31Reported-$12.31M(m)(m)(m)-62.49%$60.00K-$7.03M$2.72M$2.55M$26.84M$11.00K
2025-12-31Reported-$3.56M(m)(m)(m)-17.47%(m)(m)(m)(m)(m)(m)
2025-09-30Reported-$7.80M*-$7.91M$105.00K*$19.91M-39.18%*$170.00K*-$8.72M*$2.71M$3.35M$21.75M-$79.00K
2025-06-30Reported-$11.54M*-$11.67M$125.00K*$19.56M-59.00%*$210.00K*-$7.54M*$2.98M$4.39M$23.87M$40.00K
2025-03-31Reported-$13.71M(m)(m)(m)-78.31%$0.00-$11.61M$2.41M$4.43M$24.52M$41.00K
2024-12-31Reported-$11.75M(m)(m)(m)-61.62%(m)(m)(m)(m)(m)(m)
2024-09-30Reported-$11.07M*-$11.23M$158.00K*$20.16M-54.92%*$51.00K*$362.00K*$3.25M$4.75M$23.39M$166.00K
2024-06-30Reported-$12.46M*-$12.65M$186.00K*$21.37M-58.33%*$80.00K*-$9.47M*$3.02M$4.32M$26.68M$15.00K
2024-03-31Reported-$14.53M(m)(m)(m)-75.43%$117.00K-$9.79M$2.79M$4.64M$26.56M$17.00K
2023-12-31Reported-$10.95M(m)(m)(m)-58.40%(m)(m)(m)(m)(m)(m)
2023-09-30Reported-$13.25M*-$13.41M$160.00K*$20.01M-66.23%*$304.00K*-$9.83M*$2.68M$4.24M$26.50M$78.00K
2023-06-30Reported-$15.04M*-$15.19M$149.00K*$23.47M-64.07%*$97.00K*-$13.49M*$3.38M$5.22M$30.06M$8.00K
2023-03-31Reported-$17.42M(m)(m)(m)-92.55%$126.00K-$17.38M$3.05M$4.67M$28.68M$14.00K
2022-09-30Reported(m)-$21.84M(m)$18.68M(m)$272.00K*-$20.19M*$2.93M$6.05M$31.54M$19.00K
2022-06-30Reported(m)-$22.86M(m)$17.23M(m)$342.00K*-$18.30M*$2.74M$5.93M$31.43M$9.00K
2022-03-31Reported(m)-$22.19M(m)$14.88M(m)$227.00K-$21.97M$3.03M$5.65M$28.39M$9.00K
2021-09-30Reported(m)-$14.03M(m)$13.10M(m)$287.00K*-$16.51M*$2.06M$4.28M$20.79M$16.00K
2021-06-30Reported(m)-$11.08M(m)$12.54M(m)$265.00K*-$12.44M*$2.31M$3.55M$17.76M$22.00K
2021-03-31Reported(m)-$11.66M(m)$8.63M(m)$104.00K-$12.87M$2.30M$3.44M$14.55M$52.00K
2020-09-30Reported(m)-$7.36M(m)$8.65M(m)$119.00K*-$8.62M*$2.62M$2.16M$11.23M$8.00K
2020-06-30Reported(m)-$7.69M(m)$3.50M(m)(m)(m)$2.08M$1.44M$7.66M$6.00K

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported-$36.61M(m)(m)(m)-47.32%$224.00K-$29.69M$10.70M$14.61M$89.16M$10.00K
2024-12-31Reported-$49.82M(m)(m)(m)-62.38%$385.00K-$22.35M$11.58M$17.99M$100.83M$236.00K
2023-12-31Reported-$56.66M(m)(m)(m)-69.90%$791.00K-$47.18M$11.88M$17.56M$108.89M$110.00K
2022-12-31Reported(m)-$83.95M(m)$71.33M(m)$970.00K-$75.97M$12.36M$22.86M$120.06M$47.00K
2021-12-31Reported(m)-$51.48M(m)$48.96M(m)$813.00K-$52.54M$8.61M$15.63M$76.19M$188.00K
2020-12-31Reported(m)-$32.19M(m)$27.64M(m)$953.00K-$32.17M$9.21M$8.87M$41.74M$61.00K

Similar stocks

Stock NameCountryMarket CapPE Ratio
NeuroPace Inc (NPCE)United States$0.480B-28.52
ClearPoint Neuro, Inc. (CLPT)United States$0.446B-15.74
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)United States$0.519B27.16
CERUS CORP (CERS)United States$0.525B-86.40
CARLSMED, INC. (CARL)United States$0.405B
DELCATH SYSTEMS, INC. (DCTH)United States$0.558B820.33
Orthofix Medical Inc. (OFIX)$0.373B
SS Innovations International, Inc. (SSII)$0.589B-64.06
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B
Orchestra BioMed Holdings, Inc. (OBIO)United States$0.356B-4.39